Symbol
QCLS on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership
8.48M shares
Security Ownership
74%

PharmaCyte Biotech, Inc. ownership in Q/C TECHNOLOGIES, INC. Common Stock, par value $0.001 per share (QCLS)

2025-11-18 - PharmaCyte Biotech, Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.48M shares of Q/C TECHNOLOGIES, INC. Common Stock, par value $0.001 per share (QCLS). This represents 74% percent ownership of the company.